OCLS Share Price

Open 4.82 Change Price %
High 4.95 1 Day 0.08 1.64
Low 4.81 1 Week 0.00 0.00
Close 4.95 1 Month 0.00 0.00
Volume 13830 1 Year 4.09 475.58
52 Week High 5.65
52 Week Low 3.57
OCLS Important Levels
Resistance 2 5.08
Resistance 1 5.03
Pivot 4.90
Support 1 4.87
Support 2 4.82
NASDAQ USA Most Active Stocks
YHOO 52.58 0.00%
YHOO 52.58 0.00%
YHOO 52.58 0.00%
DCTH 0.16 -33.33%
FTR 1.22 8.93%
FTR 1.22 8.93%
ASTI 0.00 0.00%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
More..
NASDAQ USA Top Gainers Stocks
OPXAW 0.12 200.00%
AVEO 1.25 71.23%
LOCM 0.09 50.00%
MYRX 0.09 50.00%
SNCR 16.24 33.33%
QUIK 1.60 31.15%
WRES 0.09 28.57%
IIN 8.35 27.48%
IIN 8.35 27.48%
IIN 8.35 27.48%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
TOPS 0.80 -66.67%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
SPIR 0.01 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
More..

Oculus Innovative Sciences, Inc. (NASDAQ: OCLS)

OCLS Technical Analysis 5
As on 5th Dec 2016 OCLS Share Price closed @ 4.95 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 2.59 & Strong Buy for SHORT-TERM with Stoploss of 4.39 we also expect STOCK to react on Following IMPORTANT LEVELS.
OCLS Target for June
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
OCLS Other Details
Segment EQ
Market Capital 26042852.00
Sector Healthcare
Industry Medical Instruments & Supplies
Offical website http://www.oculusis.com
OCLS Address
OCLS
1129 North Mcdowell Boulevard
Petaluma, CA 94954
United States
Phone: 707-283-0550
Fax: 707-283-0551
OCLS Latest News
Interactive Technical Analysis Chart Oculus Innovative Sciences, Inc. ( OCLS NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Oculus Innovative Sciences, Inc.
OCLS Business Profile
Oculus Innovative Sciences, Inc. is a global healthcare company that designs, produces, and markets prescription and non-prescription products in over 20 countries.The Company�s focus is on the commercialization of its technology platform called Microcyn Technology. Outside the United States, its Microcyn Technology products have a CE Mark device approval in Europe for debriding, irrigating and moistening acute and chronic wounds in comprehensive wound treatment by reducing microbial load and creating a moist environment. In Mexico, it is approved as a drug for antiseptic. In India, its technology has a drug license for cleaning and debriding in wound management. In China, it has obtained a medical device approval by the State Food and Drug Administration for reducing the propagation of microbes in wounds and creating a moist environment for wound healing.